Gene · 2057
Papers3,982
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,982
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CD163+ macrophages coordinate erythroblastic Island formation and iron metabolism to enable glucocorticoid-induced erythropoiesis. | Biomark Res | 2026 | 42365354 | PubTator, text mining | PubMed |
| Therapeutic Effects of Nanoparticles Loaded with Combined Sense and Anti-Sense of EpoR Plasmids to Enhance Angiogenesis. | Res Sq | 2026 | 42326510 | PubTator, text mining | PubMed |
| Retinoic acid as a stage-specific modulator of hematopoietic lineage fate from human pluripotent stem cells. | Cell Commun Signal | 2026 | 42321817 | PubTator, text mining | PubMed |
| Development of an Enzyme-Linked Immunosorbent Assay for Pegmolesatide in Doping Analysis: An Initial Testing Method. | Drug Test Anal | 2026 | 42321008 | PubTator, text mining | PubMed |
| Liquid Chromatographic Methods for Microsampling in Sports Drug Monitoring: Progress in DBS and VAMS. | Biomed Chromatogr | 2026 | 42289360 | PubTator, text mining | PubMed |
| Abnormal Stress Reduced miR-330 Supplementation Alleviates Osteoarthritis Progression by Suppressing Osteochondral Catabolism. | Aging Cell | 2026 | 42212804 | PubTator, text mining | PubMed |
| Amelioration of CKD-induced cardiomyocyte hypertrophy by pegmolesatide: involvement of JAK2/STAT3 inhibition and mitochondrial protection. | Front Pharmacol | 2026 | 42212269 | PubTator, text mining | PubMed |
| Computational Screening of Microbial Metabolites as Erythropoietin (EPO) Mimetics for the Treatment of Anemia. | Biomed Eng Comput Biol | 2026 | 42206225 | PubTator, text mining | PubMed |
| The Kidney-immune Axis: How Erythropoietin Regulates Tolerance and Rejection. | Transplantation | 2026 | 42165263 | PubTator, text mining | PubMed |
| Tea polyphenols suppress the malignant progression of renal cancer cells by targeting Nosip. | Transl Androl Urol | 2026 | 42164384 | PubTator, text mining | PubMed |
| Recombinant human erythropoietin therapy in patients with cancer: efficacy, risks and the controversy of EpoR expression. | Drugs Context | 2026 | 42157951 | PubTator, text mining | PubMed |
| EPAS1 is associated with human muscle fiber composition and endurance phenotypes. | Physiol Rep | 2026 | 42157436 | PubTator, text mining | PubMed |
| Unmasking erythroid suppression: the hidden culprit in renal anemia pathogenesis. | Nephrol Dial Transplant | 2026 | 42148807 | PubTator, text mining | PubMed |
| Erythropoietin targets parvalbumin-positive inhibitory neurons and microglia to promote plasticity in the thalamic reticular nucleus. | Neuropharmacology | 2026 | 42142650 | PubTator, text mining | PubMed |
| Audiogenic Kindling Stimulation Fails to Induce Cerebral Overexpression of P-Glycoprotein and Limbic Crises in the GASH/Sal Model of Epilepsy. | Int J Mol Sci | 2026 | 42074021 | PubTator, text mining | PubMed |
| In silico analysis of gene expression signatures and drug repurposing associated with metastatic progression in melanoma (skin cancer). | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 42068380 | PubTator, text mining | PubMed |
| Circulating erythropoietin concentration associates with thromboembolism in sickle cell disease. | Br J Haematol | 2026 | 42052798 | PubTator, text mining | PubMed |
| Combinatorial base editing couples disease correction with lineage amplification in hematopoietic stem and progenitor cells. | bioRxiv | 2026 | 42039379 | PubTator, text mining | PubMed |
| Erythropoietin receptor upregulation is associated with tubular injury severity in human acute kidney injury. | Ren Fail | 2026 | 41947411 | PubTator, text mining | PubMed |
| Overexpression of the erythropoietin receptor is associated with upregulation of tubulin beta 6 and paclitaxel resistance in ovarian adenocarcinoma cells. | Acta Chim Slov | 2026 | 41918423 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2057/papers?page=2